Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)

BACKGROUND: Effective treatment options for inoperable, metastatic, or recurrent canine pheochromocytomas are lacking. In humans, specific germline mutations exist that drive the development of pheochromocytomas. Pharmaceutical blockade of these abnormalities with small molecule inhibitors are an ef...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Vet Res
Autors principals: Musser, Margaret L., Taikowski, Kathryn L., Johannes, Chad M., Bergman, Philip J.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122699/
https://ncbi.nlm.nih.gov/pubmed/30176869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-018-1597-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars